Augmented Th17 Differentiation Leads to Cutaneous and Synovio‐Entheseal Inflammation in a Novel Model of Psoriatic Arthritis
- 13 February 2018
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 70 (6) , 855-867
Abstract
Objective: To introduce a novel preclinical animal model of psoriatic arthritis (PsA) in R26Stat3Cstopfl/fl CD4Cre mice, and to investigate the role of Th17 cytokines in the disease pathogenesis.Methods: We characterized a novel murine model of Th17‐driven cutaneous and synovio‐entheseal disease directed by T cell–specific expression of a hyperactive Stat3 allele. By crossing R26Stat3Cstopfl/fl CD4Cre mice onto an interleukin‐22 (IL‐22)–knockout background or treating the mice with a neutralizing antibody against IL‐17, we interrogated how these Th17 cytokines could contribute to the pathogenesis of PsA.Results: R26Stat3Cstopfl/fl CD4Cre mice developed acanthosis, hyperkeratosis, and parakeratosis of the skin, as well as enthesitis/tendinitis and periarticular bone erosion in different joints, accompanied by osteopenia. T cell–specific expression of a hyperactive Stat3C allele was found to drive the augmented Th17 response in these animals. Careful characterization of the mouse bone marrow revealed an increase in osteoclast progenitor (OCP) and RANKL‐producing cells, which contributed to the osteopenia phenotype observed in the mutant animals. Abrogation of the Th17 cytokines IL‐17 or IL‐22 improved both the skin and bone phenotype in R26Stat3Cstopfl/fl CD4Cre mice, revealing a central role of Th17 cells in the regulation of OCP and RANKL expression on stromal cells.Conclusion: Perturbation of the IL‐23/Th17 axis instigates Th17‐mediated inflammation in R26Stat3Cstopfl/fl CD4Cre mice, leading to cutaneous and synovio‐entheseal inflammation and bone pathologic features highly reminiscent of human PsA. Both IL‐17A and IL‐22 produced by Th17 cells appear to play critical roles in promoting the cutaneous and musculoskeletal inflammation that characterizes PsA.Keywords
Funding Information
- National Institutes of Health (F31‐CA‐171596‐02, R01‐AR‐056672, R01‐AR‐068593)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (F31‐AR‐070094, T32‐AI‐100853‐3, R03‐AR‐072182, K23‐AR‐064318)
- Instituto de Salud Carlos III
- Arthritis Foundation
This publication has 48 references indexed in Scilit:
- T Cell–Derived IL-17 Mediates Epithelial Changes in the Airway and Drives Pulmonary NeutrophiliaThe Journal of Immunology, 2013
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialThe Lancet, 2013
- Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis”Biological Procedures Online, 2012
- Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor functionJournal of Clinical Investigation, 2012
- The Th17/IL-23 Axis and Natural Immunity in Psoriatic ArthritisInternational Journal of Rheumatology, 2012
- Functional role of IL-22 in psoriatic arthritisArthritis Research & Therapy, 2012
- Regulation of bone by the adaptive immune system in arthritisArthritis Research & Therapy, 2011
- Signal transduction and Th17 cell differentiationMicrobes and Infection, 2009
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionJournal of Experimental Medicine, 2006
- Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targetingProceedings of the National Academy of Sciences, 2006